Plan

pub-00

Bibliographie

pub-00
[1] Organisation Mondiale de la Sante. Trypanosomiase humaine africaine (maladie du sommeil) [En ligne].2014 [consulté le 20 mars 2014]. Disponible : http://www.who.int/mediacentre/factsheets/fs259/fr/
[2] Forde RM. Some clinical notes on a European patient in whose blood a trypanosome was observed. J Trop Med 1902, 5:261-263.
[3] Dutton JE. Preliminary note upon a trypanosome occurring in the blood of man. Thompson Yates Lab Rep 1902, 4:455-468.
[4] Castellani A. On the discovery of a species of Trypanosoma in the cerebro-spinal fluid of  ases of sleeping sickness. Proc R Soc Lond 1903, 71:501-508.
[5] D. Bruce.  Note on the discovery of a New Trypanosoma, Proceedings of the Royal Physical Society of Edinburgh, IXIX, 1902, p. 496 ;
[6] MULLIGAN H.W. (1970) The Ahican Trypanosomiases. Eds Allen & Unwin LTD, London
[7] AUSTEN E.E., 1903 A monograph of the Tsetse flies (genus Glossina, Westwood). British Museum, 327 p.
[8] Bruce D. Preliminary report on the tsetse fly disease or nagana in Zululand Durban: Bennett and Davis; 1895.
[9] World Health Organization: African trypanosomiasis (sleeping sickness). 2006 [http://www.who.int/mediacentre/factsheets/fs259/en/]. World Health Organ Fact Sheet.
[10] Hide G: History of sleeping sickness in East Africa. Clin Microbiol Rev 1999, 12:112-125.
[11] WHO/CDS/CSR/ISR/2000.1: Chapter 8 – African trypanosomiasis. In WHO Report on Global Surveillance of Epidemic-prone Infectious Diseases World Health Organization; 2000:95-106.
[12]  de Raadt P: The history of sleeping sickness. 2005 [http://www.who.int/ trypanosomiasis_african/country/history/en/print.html]. World Health Org
[13] Cox FEG: History of sleeping sickness (African trypanosomiasis). Infect Dis Clin N Am 2004, 18:231-245.
[14] Winkle S: Geißeln der Menschheit. Kulturgeschichte der Seuchen Düsseldorf: Artemis & Winkler; 2005.
[15] Bray PG, Barrett MP, Ward SA, de Koning HP: Pentamidine uptake and resistance in pathogenic protozoa: past, present and future. Trends Parasitol 2003, 19:232-239
[16] Meyskens FL Jr, Gerner EW: Development of difluoromethylornithine (DFMO) as a chemoprevention agent. Clin Cancer Res 1999, 5:945-951.
[17] Hoare CA. The Trypanosomes of Mammals. A Zoological Monograph. Oxford and Edinburgh: Blackwell Scientific Publications; 1972.
[18] LAVEISSIERE  (c), PENCHENIER (L). Manuel de lutte contre la maladie du sommeil. Paris  : IRD Éditions ; 2005 p. 48.
[19] Kennedy P.G. Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness). Lancet Neurol., 2013, 12, 186-194.
[20] Brun R, Blum J, Chappuis F, Burri C. Human African trypanosomiasis. Lancet 2010; 375: 148–59.
[21] LAVEISSIERE  (c), PENCHENIER (L). Manuel de lutte contre la maladie du sommeil. Paris : IRD Éditions ; 2005 p. 50.
[22] Vickerman K, Tetley L, Hendry KA, Turner CM. Biology of African trypanosomes in the tsetse fly. Biol Cell. 1988;64(2):109–119
[23] Van Den Abbeele J, Claes Y, Van Bockstaele D, Le Ray D, Coosemans M. Trypanosoma brucei spp. Development in the tse-tse fly: characterization of the post-mesocyclic stage in the foregut and the proboscis. Parasitology 1999 ; 118 : 469-478
[24] LAVEISSIERE  (c), PENCHENIER (L). Manuel de lutte contre la maladie du sommeil. Paris  : IRD Éditions ; 2005 p. 52.
[25] Welburn SC, Maudlin I. Tse-tse trypanosome interactions: rites of passage. Parasitol Today 1999 ; 15 : 399-403
[26] LAVEISSIERE  (c), PENCHENIER (L). Manuel de lutte contre la maladie du sommeil. Paris : IRD Éditions ; 2005 p. 61.
[27] LAVEISSIERE  (c), PENCHENIER (L). Manuel de lutte contre la maladie du sommeil. Paris : IRD Éditions ; 2005 p. 62.
[28] Vanhollebeke, B. et Pays, E., 2010. The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill. Molecular Microbiology, 76 (4): 806-814.
[29] Pays, E. et Vanhollebeke, B., 2008. Mutual self-defence: the trypanolytic factor story. Microbes and Infection, 10 (9): 985-989.
[30] Genovese, G., Friedman, D.J., Ross, M.D., Lecordier, L., Uzureau, P., Freedman, B.I., Bowden, D.W., Langefeld, C.D., Oleksyk, T.K., Knob, A.U., Bernhardy, A., Hicks, P.J., Appel, G.B., Nelson, G.W., Vanhollebeke, B., Winkler, C.A., Kopp, J.B., Pays, E., and Pollak, M.R. (2010) Association of trypanolytic apoL1 variants with kidney disease in African-Americans. Science 329, 841-845.
[31] Leslie, M., 2010. Kidney disease is parasite-slaying protein's downside. Science, 329 (5989): 263.
[32] Pierrick Uzureau, Sophie Uzureau, Laurence Lecordier, Frédéric Fontaine, Patricia Tebabi, Fabrice Homblé, Axelle Grélard, Vanessa Zhendre, Derek P. Nolan, Laurence Lins, Jean-Marc Crowet, Annette Pays, Cécile Felu, Philippe Poelvoorde, Benoit Vanhollebeke, Soren K. Moestrup, Jeppe Lyngsø, Jan Skov Pedersen, Jeremy C. Mottram, Erick J. Dufourc, David Pérez-Morga & Etienne Pays Mechanism of Trypanosoma brucei gambiense resistance to human serum Nature 21 aout 2013, 501, 430-434 doi:10.1038/nature12516. Disponible à l’URL: http://www.nature.com/nature/journal/vaop/ncurrent/full/nature12516.html
[33]   Pays E, Vanhollebeke B. Human innate immunity against African trypanosomes. Curr Opin Immunol.2009;21(5):493–498.
[34]   Mehlitz D, Zillmann U, Scott C, et al. Epidemiological studies on the animal reservoir of Gambiense sleeping sickness. Part III. Characterization of trypanozoon stocks by isoenzymes and sensitivity to human serum. Tropen Med Parasitol 1982 ; 33 : 113-8.
[35] Nkinin S.W., Njiokou F., Penchenier L., Grébaut P., Simo G., Ngassam P., Herder S., 2001 - Characterisation of Trypanosoma brucei s.l. by isoenzymes in the central african sub-region. ISCTRC, OAU/STRC, 26th Meeting, Ouagadougou
[36] Warren Photographic. Tsetse Fly (Glossina morsitans) excreting fluid after blood meal [En ligne] c2012-2014 [consulté le 30 avril 2014]. Disponible : http://www.warrenphotographic.co.uk/16224-tsetse-fly-excreting-fluid-after-sucking-blood
[37] Warren Photographic. Tsetse Fly (Glossina morsitans) sucking blood from a human arm. [En ligne] c2012-2014 [consulté le 30 avril 2014]. Disponible : http://www.warrenphotographic.co.uk/06348-tsetse-fly-biting
[38] KETILE D.S. (1995) Medical an Veterinary Entomology. 2nd Edition, Eds CAB International.
[39] LAVEISSIERE  (c), PENCHENIER (L). Manuel de lutte contre la maladie du sommeil. Paris : IRD Éditions ; 2000 p. 55.
[40] LAVEISSIERE  (c), GREBAUT (P), PENCHENIER (L), HERDER (S). Les glossines vectrices de la Maladie du Sommeil. Paris : IRD Éditions ; 2000 p. 35.
[41] FORD  (J.), KATONDO (K.M.), 1973 - Maps of tsetse fly (Glossina) distribution in Africa, 1973, according to sub-generic groups on scale of 1 :5,000 000  (plus a set of 9 maps in colour). Bull. Anim. Hlth. Production, 25, 187-1 93.
[42] CHALLIER (A.), 1973 - Ecologie de Glossina palpalis gambiensis Vanderplank 1949 (Diptera ; Muscidae) en savane d'Afrique occidentale. Mém. ORSTOM,  n° 64, 274p.
[43] CUISANCE D. (1995) Les grandes endémies parasitaires à transmission vectorielle. Glossines et trypanosomes. Cours de DEA de Parasitologie, Montpellier, France.
[44] PHELPS (R.J.) & VALE (G.A.), 1978 - Studies on populations of Glossina morsitans morsitans and G. pallidipes (Diptera ; Glossinidae) in Rhodesia. J. appl. Ent.,  15, 743-76
[45] CUISANCE (D.) & FEVRIER (J.), 1983 - Etude sur le pouvoir de dispersion des glossines.Rapport IEMVT./CRTA, 82p.
[46] WEITZ (B.), 1963 - The feeding habits of Glossina: Bull. Wld. Hlth Org., 28, 71 1-729.
[47] GOUTEUX (J.P.), LAVEISSIERE (C.) & BOREHAM (P.F.L.), 1982 - Ecologie des glossines en secteur pré-forestier de Côte d'Ivoire. 2. Les préférences trophiques de Glossina palpalis s.1. Cah. ORSTOM, Sér. Ent. méd. Parasitol., XX,  3-1 8.
[48]   DE LA ROCQUE (S), CUISANCE (D), La Tsé-tsé : une mouche singulière et dangereuse.  Insecte.2005 ; N°136 : 27-31
 [49]   LAVEISSIERE (C.) & SANE (B.), 1994 - Régulateur de croissance et piégeage pour la lutte contre Glossina palpalis palpalis en Côte d'Ivoire : essai sur le  terrain de l'OMS 3019 (Pyriproxyfen, Sumitomo). Insect Sci. Applic., 15,  105-1 10.
[50] D'ALMEIDA (J.F.), 1985 - Contribution à I'étude du piégeage de Glossina longipalpis Wiedemann 1830 en zone de savane guinéenne de Côte d'Ivoire. Mémoire de DEA/CEMV/Bouaké, n°11, 72p.
[51] LAVEISSIERE (C.), DYEMKOUMA (A.), KIENOU (J.P.) & TRAORE (T.), 1976 - Enquête entomologique et épidémiologique dans le foyer de trypanosomiase humaine de Kolda (Sénégal). Rapport OCCGE/Centre Muraz, no 13/ENT/76, 18p.
[52] CHALLIER (A.), 1973 - La capacité vectorielle des glossines. Rapport OCCGE/Centre Muraz, no 5.416/Doc. Tech. OCCGE, 22p.
[53] MEDA (A.H.), LAVEISSIERE (C.), DE MUYNCK (A.), DOUA (F.) et DIALLO (P.B.),  1993 - Les facteurs de risque de la Trypanosomiase humaine africaine dans les foyers endémiques de Côte d'Ivoire. Médecine tropicale, 53, 83-92.
[54] World Health Organization. Report of a WHO meeting on elimination of African trypanosomiasis (Trypanosoma brucei gambiense), 3-5 December 2012, Geneva, Switzerland. WHO/HTM/NTD/IDM 2013.4 apps.who.int/ iris/bitstream/10665/79689/1/WHO_HTM_NTD_IDM_2013.4_eng.pdf(accessed 27 May 2013)
[55] Brun R, Blum J, Chappuis F, Burri C. Human African trypanosomiasis. Lancet 2010; 375: 148–59.
[56] Kennedy PGE. The fatal sleep. Edinburgh: Luath Press, 2010.
[57] Picozzi K, Fèvre EM, Odiit M, et al. Sleeping sickness in Uganda: a thin line between two fatal diseases. BMJ 2005; 331: 1238–41.
[58] Cecchi G et al. Towards the Atlas of human African trypanosomiasis. International Journal of Health Geographics, 2009, 8:155.
[59] Simarro PP, Cecchi G, Franco JR, et al. Estimating and mapping the population at risk of sleeping sickness. PLoS Negl Trop Dis. 2012;6(10):e1859
[60] MWANGI DM, HOPKINS J, LUCKINS AG - Trypanosoma congolense infection in sheep: Cellular phenotypes in lymph and lymph nodes associated with skin reactions. J Comp Pathol 1996 ; 114 : 51-61.
[61] OLSSON T, BAKHIETM, EDLUND C et al. - Bidirectional activating signals between Trypanosoma brucei and CD8+ T cells:A trypanosome-released factor triggers interferon-gamma production that stimulates parasite growth. Eur J Immunol 1991 ; 21 : 2447-54.
[62] OKOMO-ASSOUMOU MC, DAULOUEDE S, LEMESRE JL et al. - Correlation of high serum levels of tumor necrosis factor-alpha with disease severity in human African trypanosomiasis. Am J Trop Med Hyg 1995 ; 53 : 539-43.
[63] BUGUETA, BANZET S, BOUTEILLE B et al. - NO a cornerstone in sleeping sickness: Voltammetric assessment in animal and man. In « MORAVEC J, TAKEDA N, SINGAL PK -Adaptation Biology and Medicine, vol 3, chapter 23». Narosha Publishing House ed, New Dehli, India, 2002, pp 221-9.
[64] VINCENDEAU P, BOUTEILLE B - Immunology and immunopathology of African trypanosomiasis. An Acad Bras Cienc 2006 ; 78 : 645-65.
[65] KOFFI M, SOLANO P, DENIZOT M et al. - Aparasitemic serological suspects in Trypanosoma brucei gambiense human African trypanosomiasis: a potential human reservoir of parasites? Acta Trop 2006 ; 98 : 183-8.
[66] DUBOIS ME, DEMICK KP, MANSFIELD JM - Trypanosomes expressing a mosaic variant surface glycoprotein coat escape early detection by the immune system. Infect Immun 2005 ; 73 : 2690-7.
[67] DUMAS M, BISSER S - Clinical aspects of human African trypanosomiasis. In «DUMAS M, BOUTEILLE B, BUGUET A - Progress in human African Trypanosomiasis, sleeping sickness». Springer-Verlag, Paris (France), 1999, pp. 215-23.
[68] KENNEDY PG - Human African trypanosomiasis of the CNS: Current issues and challenges. J Clin Invest 2004 ; 113 : 496-504.
[69] BUGUET A, BERT J, TAPIE P et al. - - Sleep-wake cycle in human African trypanosomiasis. J Clin Neurophysiol 1993 ; 10 : 190-6.
[70] KOTEN JW, DE RAADT P - Myocarditis in Trypanosoma rhodesiense infections. Trans R Soc Trop Med Hyg 1969 ; 63 : 485-9.
[71] BRAAKMAN HM, VAN DE MOLENGRAFT FJ, HUBERTWW, BOERMAN DH - Lethal African trypanosomiasis in a traveller : MRI and neuropathology. Neurology 2006 ; 66 : 1094-6.
[72] CARPENTER MB, SUTIN J - Human neuroanatomy. Eight edition.Williams andWilkins ed, 1983, 872 p.
[73] DHIB-JALBUT S, MCFARLIN DE, MCFARLAND HF - Measles virus-polypeptide specificity of the cytotoxic T-lymphocyte response in multiple sclerosis. J Neuroimmunol 1989 ; 21 : 205-212.
[74] PRINEAS JW - Multiple sclerosis: Presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord. Science 1979 ; 203 : 1123-5.
[75] WIDNER H, MOLLER G, JOHANSSON BB - Immune response in deep cervical lymph nodes and spleen in the mouse after antigen deposition in different intracerebral sites. Scand J Immunol 1988 ; 28 : 563-71.
[76] KIVISAKK P, MAHAD DJ, CALLAHANMK et al. - Expression of CCR7 in multiple sclerosis: Implications for CNS immunity. Ann Neurol 2004 ; 55 : 627-8.
[77] HICKEYWF, KIMURA H - Graft-vs.-host disease elicits expression of class I and class II histocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system. Proc Natl Acad Sci USA 1987 ; 84 : 2082-6.
[78] BAILEY SL, CARPENTIER PA, MCMAHON EJ et al. - Innate and adaptive immune responses of the central nervous system. Crit Rev Immunol 2006 ; 26 : 149-88.
[79] MCMAHON EJ, BAILEY SL, MILLER SD - CNS dendritic cells: Critical participants in CNS inflammation? Neurochem Int 2006 ; 49 :195-203.
[80] WEBB AA, MUIR GD - The blood-brain barrier and its role in inflammation. J Vet Intern Med 2000 ; 14 : 399-411.
[81] GRAB DJ, NIKOLSKAIA O, KIMYV et al. -African trypanosome interactions with an in vitro model of the human blood-brain barrier. J Parasitol 2004 ; 90 : 970-9.
[82] MULENGA C, MHLANGA JD, KRISTENSSON K, ROBERTSON B - Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model. Neuropathol Appl Neurobiol 2001 ; 27 : 77-85.
[83] SCHULTZBERG M, AMBATSIS M, SAMUELSSON EB et al. - Spread of Trypanosoma brucei to the nervous system: Early attack on circumventricular organs and sensory ganglia. J Neurosci Res 1988 ; 21 : 56-61.
[84] PHILIP KA, DASCOMBE MJ, FRASER PA, PENTREATH VW - Blood-brain barrier damage in experimental African trypanosomiasis. Ann Trop Med Parasitol 1994 ; 88 : 607-16.
[85] KEITAM, BOUTEILLE B, ENANGA B et al. - Trypanosoma brucei brucei:A long-term model of humanAfrican trypanosomiasis in mice, meningoencephalitis, astrocytosis, and neurological disorders. Exp Parasitol 1997 ; 85 : 183-92.
[86] TIZARD I, NIELSEN KH, SEED JR, HALL JE - Biologically active products fromAfrican Trypanosomes. Microbiol Rev 1978 ; 42 : 664-81.
[87] PENTREATHVW, ALAFIATAYO RA, BARCLAY GR et al. - Endotoxin antibodies inAfrican sleeping sickness. Parasitology 1997 ; 114 : 361-65.
[88] KEITAM, VINCENDEAU P, BUGUETA et al. - Inducible nitric oxide synthase and nitrotyrosine in the central nervous system of mice chronically infected with Trypanosoma brucei brucei. Exp Parasitol 2000 ; 95 :19-27.
[89] LONSDALE-ECCLES JD, GRAB DJ - Trypanosome hydrolases and the blood-brain barrier. Trends Parasitol 2002 ; 18 : 17-9.
[90] NIKOLSKAIA OV, DE A LIMA AP, KIMYV et al. - Blood-brain barrier traversal by African trypanosomes requires calcium signalling induced by parasite cysteine protease. J Clin Invest 2006 ; 116 : 2739-47.
[91] VISWAMBHARAN H, SEEBECK T,YANG Z - Enhanced endothelial nitric oxide-synthase activity in mice infected with Trypanosoma brucei. Int J Parasitol 2003 ; 33 : 1099-104.
[92] GIRARD M, BISSER S, COURTIOUX B et al. - In vitro induction of microglial and endothelial cell apoptosis by cerebrospinal fluids from patients with human African trypanosomiasis. Int J Parasitol 2003 ; 33 : 713-20.
[93] STILES JK,WHITTAKER J, SARFO BY et al. - Trypanosome apoptotic factor mediates apoptosis in human brain vascular endothelial cells. Mol Biochem Parasitol 2004 ; 133 : 229-40.
[94] MASOCHA W, ROBERTSON B, ROTTENBERG ME et al. - Cerebral vessel laminins and IFN-gamma define Trypanosoma brucei brucei penetration of the blood-brain barrier. J Clin Invest 2004 ; 114 : 689-94.
[95] PENTREATH VW, OWOLABI AO, DOUA F - Survival of Trypanosoma brucei brucei in cerebrospinal fluid. Ann Trop Med Parasitol 1992 ; 86 : 29-34.
[96] ENANGA B, BURCHMORE RJ, STEWART ML, BARRETT MP - Sleeping sickness and the brain. Cell Mol Life Sci 2002 ; 59 : 845-58.
[97] BRENIER-PINCHARTMP, PELLOUX H, DEROUICH-GUERGOUR D,AMBROISE-THOMAS P - Chemokines in host-protozoan-parasite interactions. Trends Parasitol 2001 ; 17 : 292-6.
[98] LEJON V, LARDON J, KENIS G et al. - Interleukin (IL)-6, IL-8 and IL-10 in serum and CSF of Trypanosoma brucei gambiense sleeping sickness patients before and after treatment. Trans R Soc Trop Med Hyg 2002 ; 96 : 329-33.
[99] COURTIOUX B, BODA C, VATUNGA G et al. - A link between chemokine levels and disease severity in human African trypanosomiasis. Int. J. Parasitol. 2006 ; 36 : 1057-65.
[100] AMEVIGBE MD, JAUBERTEAU-MARCHAN MO, BOUTEILLE B et al. - Human African trypanosomiasis: Presence of antibodies to galactocerebrosides. Am J Trop Med Hyg 1992 ; 47 : 652-62.
[101] OKOMO-ASSOUMOUMC, GEFFARDM, DAULOUEDE S et al. - Circulating antibodies directed against tryptophan-like epitopes in sera of patients with human African trypanosomiasis. Am J Trop Med Hyg 1995 ; 52 : 461-7.
[102] AYED Z, BRINDEL I, BOUTEILLE B et al. - Detection and characterization of autoantibodies directed against neurofilament proteins in human African trypanosomiasis. Am J Trop Med Hyg 1997 ; 57 : 1-6.
[103] LEJON V, ROSENGREN LE, BUSCHER P et al. - Detection of light subunit neurofilament and glial fibrillary acidic protein in cerebrospinal fluid of Trypanosoma brucei gambiense-infected patients. Am J Trop Med Hyg 1999 ; 60 : 94-8.
[104] PENTREATH VW - Trypanosomiasis and the nervous system. Pathology and immunology. Trans R Soc Trop Med Hyg 1995 ; 89 : 9-15.
[105] GHAFFAR(A). BLOOD AND TISSUE PROTOZOA[En ligne]. University of South Carolina. [cité le 15/04/2010] .Disponible à l’URL : http://pathmicro.med.sc.edu/parasitology/blood-proto.htm
 [106] Institut de recherche pour le développement (IRD). Les Symptômes (Phase lymphatico-sanguine) [En ligne]. Institut de recherche pour le développement (IRD).11 mai 2011 [consulté le 5 mars 2014]. Disponible à l’URL : http://www.sleeping-sickness.ird.fr/index.htm
 [107] Association Française des Enseignants de Parasitologie et Mycologie (ANOFEL).Trypanosomose Humaine Africaine (Maladie du sommeil) [En ligne].Université Médicale Virtuelle Francophone,2011 [cité le 30/04/2012]. Disponible à l’URL : http://umvf.univ-nantes.fr/parasitologie/enseignement/ maladiesommeil/ site/html/4_2.html
[108] Integrated Vector Management Human African Trypanosomiasis. [En ligne]. Integrated Vector Management,2010. Disponible à l’URL : http://www.ivmproject.net/about/index.cfm?fuseaction=static&label=hat
[109] Magnus E, Vervoort T, Van Meirvenne N. A cardagglutination test with stained trypanosomes (CATT) for the serological diagnosis of T. gambiense trypanosomiasis. Ann Soc Belg Méd Trop 1978 ; 58 : 169-176
[110] Louis F.J., Kohagne Tongue L., Eboo Eyenza V. Simarro P.P. Organisarion d'une campagne de dépistage de la Trypanosomiase humaine africaine à Trynasoma brucei gambensae . Med. Trop., 2008, 68, 11-16.
[111] Woo PT. The haematocrit centrifuge technique for the diagnosis of african trypanosomiasis. Acta Trop 1970;27: 384-386.
[112] Lanham S, Godfrey DG. Isolation of salivarian trypanosomes from man and other mammals using DEAEcellulose. Exp Parasitol 1970 ; 28 : 521-534
[113] Lumsden WH, Kimber DD, Dukes P, Haller L, Stangellini A, Duvallet G. Field diagnosis of sleeping sickness in the Ivory Coast. I. Comparison of the miniature anion exchanger/centrifugation technique with other protozoological methods. Trans R Soc Trop Med Hyg 1981;75: 242-249
[114] Aerts D, Truc P, Penchenier L, Claes Y, Le Ray D. A kit for in vitro isolation of trypanosomes in the ®eld: ®rst ®eld trial with sleeping sickness patients. Trans R Soc Trop Med Hyg 1992 ; 86 : 394-395
[115] Mugasa, C. M., Adams, E. R., Boer, K. R., Dyserinck, H. C., Buscher, P., Schallig, H. D. et Leeflang, M. M., 2012. Diagnostic accuracy of molecular amplification tests for human African trypanosomiasis: systematic review. PLoS Neglected Tropical Diseases, 6 (1): e1438.
[116] BOUTEILLE B, OUKEM O, BISSER S, DUMAS M - Treatment perspectives for human African trypanosomiasis. Fundam Clin Pharmacol 2003 ; 17 :171-81.
[117] LEJONV, ROBAYS J, N'SIESI FX et al. - Treatment Failure Related to intrathecal  immunoglobulin M (IgM) synthesis, cerebrospinal fluid IgM, and interleukin-10 in patients with hemolymphatic-stage sleeping sickness. Clin Vaccine Immunol 2007 ; 14 : 732-7.
[118] DUMAS M, BISSER S - Clinical aspects of human African trypanosomiasis. In «DUMAS M, BOUTEILLE B, BUGUET A - Progress in human African Trypanosomiasis, sleeping sickness». Springer-Verlag, Paris (France), 1999, pp. 215-23.
[119] WORLD HEALTH ORGAN TECH REP SER - Control and surveillance ofAfrican trypanosomiasis. World Report of aWHO expert committee 1998; 881 : 1-113.
[120] CATTAND P, MIEZAN BT, DE RAADT P - Human African trypanosomiasis: Use of double centrifugation of cerebrospinal fluid to detect trypanosomes. Bull World Health Organ 1988 ; 66 : 83-86.
[121] MIEZAN TW, MEDA HA, DOUA F et al. - Single centrifugation of cerebrospinal fluid in a sealed pasteur pipette for simple, rapid and sensitive detection of trypanosomes. Trans R Soc Trop Med Hyg 2000 ; 94 : 293.
[122] MIEZAN TW, MEDA HA, DOUA F et al. -Assessment of central nervous system involvement in gambiense trypanosomiasis: Value of the cerebrospinal white cell count. Trop Med Int Health 1998 ; 3 : 571-5.
[123] Kennedy PGE. Diagnosing central nervous system trypanosomiasis: two stage or not to stage? Trans R Soc Trop Med Hyg 2008; 102: 306–07.
[124] KJELDSBERG CR, KNIGHT JA - Cerebrospinal fluid. In « JOHNSON KD - Body fluids» American Society of Clinical Pathologists ed, 1993, pp 65-157.
[125] KYAMBADDE JW, ENYARU JC, MATOVU E et al. - Detection of trypanosomes in suspected sleeping sickness patients in Uganda using the polymerase chain reaction. Bull World Health Organ 2000 ; 78 : 119-24.
[126] JAMONNEAU V, SOLANO P, GARCIA A et al. - Stage determination and therapeutic decision in human African trypanosomiasis: Value of polymerase chain reaction and immunoglobulin M quantification on the cerebrospinal fluid of sleeping sickness patients in Cote d'Ivoire. Trop Med Int Health 2003 ; 8 : 589-94.
[127] BISSER S, LEJON V, PREUX PM et al. - Blood-cerebrospinal fluid barrier and intrathecal immunoglobulins compared to field diagnosis of central nervous system involvement in sleeping sickness. J Neurol Sci 2002 ; 193 : 127-35.
[128] BISSER S, OUWE-MISSI-OUKEM-BOYER ON, TOURE FS et al. - Harbouring in the brain: A focus on immune evasion mechanisms and their deleterious effects in malaria and human African trypanosomiasis. Int J Parasitol 2006 ; 36 : 529-40.
[129] Hainard, A., Tiberti, N., Robin, X., Lejon, V., Ngoyi, D. M., Matovu, E., Enyaru, J. C., Fouda, C., Ndung'u, J. M., Lisacek, F., Muller, M., Turck, N. et Sanchez, J. C., 2009. A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients. PLoS Neglected Tropical Diseases, 3 (6): e459
[130] Hainard, A., Tiberti, N., Robin, X., Ngoyi, D. M., Matovu, E., Enyaru, J. C., Muller, M., Turck, N., Ndung'u, J. M., Lejon, V. et Sanchez, J. C., 2011. Matrix metalloproteinase-9 and intercellular adhesion molecule 1 are powerful staging markers for human African trypanosomiasis. Tropical Medicine & International Health, 16 (1): 119-126.
[131] Tiberti, N., Hainard, A., Lejon, V., Courtioux, B., Matovu, E., Enyaru, J. C., Robin, X., Turck, N., Kristensson, K., Ngoyi, D. M., Vatunga, G. M., Krishna, S., Buscher, P., Bisser, S., Ndung'u, J. M. et Sanchez, J. C., 2012. Cerebrospinal fluid neopterin as marker of the meningo-encephalitic stage of Trypanosoma brucei gambiense sleeping sickness. PLoS One, 7 (7): e40909.
[132] SIMARROPP, LOUIS FJ, JANNINJ – Sleeping sickness, the forgotten disease:The consequences in the field and a proposal for the action.XXVIIth ISTRC, Pretoria,Afrique du Sud, 29/09-03/10/2003.
[133] SIMARRO PP, LOUIS FJ, JANNIN J – Lutte contre la maladie du sommeil : réflexions sur la prise de decisions. Premier Congrès International sur la mouche tsétsé et les trypanosomoses, Brazzaville, Congo, 23-25 mars 2004.
[134] NOIREAU F, LEMESRE JL, NZOUKOUDIMY – Serodiagnosis of sleeping sickness in the Republic of the Congo: Comparison of indirect immunofluorescent antibody test and card agglutination test. Trans R Soc Trop Med Hyg 1988 ; 82 : 237-40.
[135] BAFORT JM, SCHUTTE CH, GATHIRAMV – Specificity of the Testryp CATT card agglutination test in a non-sleeping-sickness area ofAfrica. S Afr Med J 1986; 69 : 541-2.
[136] Wéry M. Drugs used in the treatment of sleeping sickness (human african trypanosomiasis: HAT). Int J Antimicrob Agents 1994;4:227-238
[137] LAVEISSIERE  (c), PENCHENIER (L). Manuel de lutte contre la maladie du sommeil. Paris  : IRD Éditions ; 2005 p. 52.
[138] Collège des universitaires des Maladies Infectieuses et Tropicales (CMIT). e-Pilly TROP Maladies infectieuses tropicales [En ligne]. Paris : collège des universitaires des Maladies Infectieuses et Tropicales (CMIT) ; 2012.[consulté le 5 mars 2014] Disponible: http://www.epopi.fr/?page=fiche&id=883&cat_id=1412
[139] Bronner U, Doua F, Ericsson O, Gustafsson LL, Miézan TW, Laïs M, Rombo L. Pentamidine concentrations in plasma, whole blood and cerebrospinal ¯uid during treatment of  Trypanosoma gambiense infection in Côte-d'Ivoire. Trans R Soc Trop Med Hyg 1991 ; 85 : 608-611
[140] Friedheim EA. Mel B in the treatment of human trypanosomiasis. Am J Trop Med Hyg 1949 ; 29 : 173-180
[141] Pépin J, Milord F. African trypanosomiasis and druginduced encephalopathy: risk factors and pathogenesis. Trans R Soc Trop Med Hyg 1991 ; 85 : 222-224
[142] OMS,Comité d'experts. La trypanosomiaseafricaine : lutte et surveillance. Genève : OMS, Série rapport technique, 1998 : n° 881
[143] Edwards RW, Rodick CL, Waed SA, Avadzo K, Orme ML, Breckenbridge AM.Determination of suraminin plasmaby high performance liquid chromatography. J Chromatogr 1985 ; 343 : 224-228
[144] Klecker RW, Collins JM. Quanti®cation of suramin by reverse-phase ion paving high performance liquid chromatography. J Liquid Chromatogr 1985;8:1685-1696
[145] Baker, N.; de Koning, H. P.; Mäser, P.; Horn, D. Trends Parasitol. 2013, 29, 110-118.
[146] Baker, N.; Glover, L.; Munday, J. C.; Aguinaga Andrés, D.; Barrett, M. P.; de Koning, H. P.; Horn, D. Proc. Natl.  Acad. Sci. USA  2012, 109, 10996-11001.
[147] Barrett, M. P., Vincent, I. M., Burchmore, R. J., Kazibwe, A. J. et Matovu, E., 2011. Drug resistance in human African trypanosomiasis. [Chimiorésistance dans la trypanosomose humaine africaine.] Future Microbiology, 6 (9): 1037-1047.
[148] Torreele, E.; Bourdin Trunz, B.; Tweats, D.; Kaiser, M.; Brun, R.; Mazué, G.; Bray, M. A.; Pécoul, B. PLoS Negl. Trop. Dis. 2010, 4, e923.
[149] Barrett, M. P.; Croft, S. L. Brit. Med. Bull. 2012, 104, 175-196
[150] Kaiser, M., Bray, M. A., Cal, M., Bourdin Trunz, B., Torreele, E. et Brun, R., 2011.  Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness. Antimicrobial Agents & Chemotherapy, 55 (12): 5602-5608.
[151] Jacobs, R. T., Nare, B., Wring, S. A., Orr, M. D., Chen, D., Sligar, J. M., Jenks, M. X., Noe, R. A., Bowling, T. S., Mercer, L. T., Rewerts, C., Gaukel, E., Owens, J., Parham, R., Randolph, R., Beaudet, B., Bacchi, C. J., Yarlett, N., Plattner, J. J., Freund, Y., Ding, C., Akama, T., Zhang, Y. K., Brun, R., Kaiser, M., Scandale, I. et Don, R., 2011. SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis. PLoS Neglected Tropical Diseases, 5 (6): e1151.
[152] Tiberti, N., Lejon, V., Hainard, A., Courtioux, B., Robin, X., Turck, N., Kristensson, K., Matovu, E., Enyaru, J. C., Mumba Ngoyi, D., Krishna, S., Bisser, S., Ndung'u, J. M., Buscher, P. et Sanchez, J. C., 2013. Neopterin is a cerebrospinal fluid marker for treatment outcome evaluation in patients affected by Trypanosoma brucei gambiense sleeping sickness. PLoS Neglected Tropical Diseases, 7 (2): e2088.
[153] Bouyer(J), Desquesnes(M), Kaboré(I), Dia(M), Gilles(J), Yoni(W), Cuisance(D). Le piégeage des insectes vecteurs. CIRDES ; mars 2005 , 20 :1-12
[154] QUINLAN (R.J.) & GATEHOUSE (A.G.), 1981 - Characteristics and implications of knockdown of the tsetse flies G. m. morsitans by deltamethrin. Pestic. Sci., 12, 439-442
[155] LAVEISSIERE (C.), COURET (D.) et TRAORE (T.), 1985 - Tests d'efficacité et de rémanence d'insecticides utilisés en imprégnation sur tissus pour Ia lutte par piégeage contre les glossines. 1. Protocole expérimental. L'effet knockdown des pyréthrinoides. Cah ORSTOM, sér Ent. méd. et Parasitol., XXIIIl  61-67.